Insomnia: Difference between revisions
No edit summary |
|||
| Line 16: | Line 16: | ||
* Sleep-disruptive environmental circumstances | * Sleep-disruptive environmental circumstances | ||
* Restless legs syndrome | * Restless legs syndrome | ||
* Sleep apnea | |||
* Short duration sleep circadian rhythm disorders | * Short duration sleep circadian rhythm disorders | ||
* Chronic sleep restriction | * Chronic sleep restriction | ||
| Line 22: | Line 23: | ||
==Evaluation== | ==Evaluation== | ||
*A personal medical history considering any medical conditions, any medications being taken, and any stressful life events/changes that could be causing insomnia | *A personal medical history considering any medical conditions, any medications being taken, and any stressful life events/changes that could be causing insomnia | ||
* | *Screen for mood disorders, PTSD, substance use disorders | ||
*A sleep history and review of sleep and wake diaries can be helpful in determining the cause | *A sleep history and review of sleep and wake diaries can be helpful in determining the cause | ||
==Management== | ==Management== | ||
* Sleep hygiene education, relaxation, and stimulus control | * Sleep hygiene education, relaxation, and stimulus control | ||
* [[Zaleplon]] for sleep onset insomnia, [[Zolpidem]] (Ambien) or [[Eszopiclone]] for sleep maintenance insomnia | |||
* [[Trazodone]], [[gabapentin]], and melatonin agonists | * [[Trazodone]], [[gabapentin]], and melatonin agonists | ||
** [[Benzodiazepines]] should be avoided (due to risks of overdose when mixed with alcohol or other substances) | ** [[Benzodiazepines]] should be avoided (due to risks of overdose when mixed with alcohol or other substances) | ||
| Line 42: | Line 44: | ||
==References== | ==References== | ||
Bonnet, MH and DL Arand. Treatment of insomnia in adults. In: UpToDate, Benca, R (Ed), UpToDate, Waltham, MA, 2017. ([https://www.uptodate.com/contents/treatment-of-insomnia-in-adults?source=see_link]) | |||
[[Category:Neurology]] | [[Category:Neurology]] | ||
Revision as of 15:48, 22 September 2017
Background
- Daytime dysfunction due to difficulty initiating sleep or lack of good sleep.
- A common emergency department complaint among patients in recovery from a substance use disorder or a psychiatric disorder
- Most substances of abuse affect sleep during active use, acute withdrawal, and with sustained abstinence
- Specific medications for insomnia should be avoided in patients with history of substance abuse.
Clinical Features
- Difficulty falling asleep and staying asleep
- Impaired daytime function (must also be reported for a diagnosis of an insomnia disorder)
- Simultaneous psychiatric, medications/substances, are usually present
Differential Diagnosis
- Alcohol use disorder
- Depression/anxiety
- Undifferentiated bipolar
- Sleep-disruptive environmental circumstances
- Restless legs syndrome
- Sleep apnea
- Short duration sleep circadian rhythm disorders
- Chronic sleep restriction
- Psychosis
Evaluation
- A personal medical history considering any medical conditions, any medications being taken, and any stressful life events/changes that could be causing insomnia
- Screen for mood disorders, PTSD, substance use disorders
- A sleep history and review of sleep and wake diaries can be helpful in determining the cause
Management
- Sleep hygiene education, relaxation, and stimulus control
- Zaleplon for sleep onset insomnia, Zolpidem (Ambien) or Eszopiclone for sleep maintenance insomnia
- Trazodone, gabapentin, and melatonin agonists
- Benzodiazepines should be avoided (due to risks of overdose when mixed with alcohol or other substances)
Disposition
- Discharge home unless patient acutely psychotic
- Follow up with primary care doctor
- Consider outpatient polysomnography-sleep study
See Also
External Links
References
Bonnet, MH and DL Arand. Treatment of insomnia in adults. In: UpToDate, Benca, R (Ed), UpToDate, Waltham, MA, 2017. ([1])